Any chance this company will ever get bought out? SCL.TO is an aggressive growth company, and could afford to issue shares and debt to buy AEGN. It could be structured in a way that is immediately accreditive to earnings.
I am surprised shorts are targeting a stock that buys back shares and issues a dividend. In fact, QCOR should borrow $300 million and buy back 5-6 million shares. That would send the stock dramatically up. Additionally, it will create a short squeeze. Regardless, this will be a tough stock to keep down considering how fast it is growing.
ACTHAR works. If your child has Infintile Spasm, you buy ACTHAR. All the drug companies know that ACTHAR works, and the soonest a competing drug can be on the market is about a decade.
If QCOR stays in the 50's, the company will be acquired.
It looks like the revised projection is still for growth QoQ. And next year should be another year of growth with as much backlog as they have? And this company is good at acquisitions, so I won't be surprised if sales and profits double again over the next 5-10 years. What's the reason to be bearish? Because some projects are delayed?
I'll go one step further and say it is Monsanto that is the most likely candidate to buy AVD. They have the cash, have a partnership, and look at acquisitions for growth.